CIK 0001408443 · Non-accelerated filer<br>Smaller reporting company
Milestone Pharmaceuticals Inc.
Sign in to watch- Ticker
- MIST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Quebec, Canada
- Entity type
- operating
- Phone
- (514) 336-0444
- Business address
- 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420, MONTREAL, Quebec, Canada, H4M 2X6
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-10 | Duty Stuart Director | Grant or award · Stock Option (right to buy) | +77,000 | 77,000 | ||
| 2026-06-10 | Wills Robert James Director | Grant or award · Stock Option (right to buy) | +77,000 | 77,000 | ||
| 2026-06-10 | Saik Andrew Director | Grant or award · Stock Option (right to buy) | +77,000 | 77,000 | ||
| 2026-06-10 | Fischer Seth H. Z. Director | Grant or award · Stock Option (right to buy) | +77,000 | 77,000 | ||
| 2026-06-10 | TOMSICEK MICHAEL JOHN Director | Grant or award · Stock Option (right to buy) | +77,000 | 77,000 | ||
| 2026-06-10 | Giles Lisa M. Director | Grant or award · Stock Option (right to buy) | +77,000 | 77,000 | ||
| 2026-06-10 | PAPA JOSEPH C Director | Grant or award · Stock Option (right to buy) | +77,000 | 77,000 | ||
| 2026-04-16 | Oliveto Joseph President and CEO | Sale 10b5-1 | −36,500 | $2.26 | $82K | 446,244 |
| 2026-02-02 | Nelson Jeffrey Edward Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +204,000 | 204,000 | ||
| 2026-02-02 | Bharucha David Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +204,000 | 204,000 | ||
| 2026-02-02 | Hasija Amit CFO & EVP of Corp. Development | Grant or award · Employee Stock Option (right to buy) | +204,000 | 204,000 | ||
| 2026-02-02 | Muller Lorenz Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +204,000 | 204,000 | ||
| 2026-02-02 | Oliveto Joseph President and CEO | Grant or award · Employee Stock Option (right to buy) | +679,000 | 679,000 | ||
| 2026-02-02 | Nelson Jeffrey Edward Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +204,000 | 204,000 | ||
| 2026-02-02 | Nelson Jeffrey Edward Chief Operating Officer | Grant or award · Restricted Stock Unit | +136,000 | 136,000 | ||
| 2026-02-02 | Bharucha David Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +204,000 | 204,000 | ||
| 2026-02-02 | Bharucha David Chief Medical Officer | Grant or award · Restricted Stock Unit | +136,000 | 136,000 | ||
| 2026-02-02 | Hasija Amit CFO & EVP of Corp. Development | Grant or award · Employee Stock Option (right to buy) | +204,000 | 204,000 | ||
| 2026-02-02 | Hasija Amit CFO & EVP of Corp. Development | Grant or award · Restricted Stock Unit | +136,000 | 136,000 | ||
| 2026-02-02 | Muller Lorenz Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +204,000 | 204,000 |
Page 1 of 9 · 163 trades